MBRX vs PGR · $8.2M cap vs P/E 10, rev $45.80B
Moleculin Biotech Inc (MBRX) versus Progressive Corp (PGR) — a side-by-side from cached financials, not a winner call.
Moleculin Biotech Inc (MBRX) is a biotechnology company listed on US.
Progressive Corp (PGR) is a insurance - property & casualty company listed on NYSE.
Latest reported MBRX revenue for 2026-06-30 was $0. Net income was -$20.5M. MBRX currently screens at market cap $8.2M.
Latest reported PGR revenue for 2026-06-30 was $45.80B. Net income was $6.13B. PGR currently screens at market cap $119.28B and trailing P/E 10.4.
MBRX currently screens at market cap $8.2M. PGR currently screens at market cap $119.28B and trailing P/E 10.4.
Not investment advice. Open the MBRX and PGR stock pages for the full models.
Not investment advice.